The Role of PON2 in the Development of Non-Allergic Asthma in Obesity
PON2 在肥胖引起的非过敏性哮喘发展中的作用
基本信息
- 批准号:10734050
- 负责人:
- 金额:$ 8.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-nitrotyrosineAcuteAddressAffectAgonistAirway DiseaseAirway FibrosisAsthmaBronchoalveolar Lavage FluidCell CountChronicCollagenCollagen Type IVCoronary arteryDataDepositionDevelopmentDietDiseaseEpithelial CellsEpitheliumExhalationExhibitsExposure toFatty acid glycerol estersFibrosisFructoseGlutathione DisulfideHomeostasisHumanIndividualInflammatoryInhalationIsoprostanesLeftLinkLipid PeroxidationLungMeasuresMediatorModelingMusNitratesNitritesNon obeseNuclearObese MiceObesityOxidative StressOzonePPAR gammaParaoxonase-2Pathway interactionsPatientsPhenotypePhysical condensationPhysiologyPioglitazonePredispositionProcessQuality of lifeReactive Oxygen SpeciesResearch ProposalsReverse Transcriptase Polymerase Chain ReactionRodentRoleSignal TransductionSignaling MoleculeStressStructure of parenchyma of lungSymptomsTherapeuticThinnessTissuesTreatment EfficacyTrichrome stainVentilatorair filterairway epitheliumairway hyperresponsivenessairway inflammationantioxidant enzymeasthmaticasthmatic patientcell typecomorbiditycytokinediet-induced obesitydietary controleosinophilic inflammationexperiencefeedinggastrointestinal epitheliumimproved outcomeinterestknock-downmouse modelnitrosative stressobese patientsoxidant stressozone exposureprofiles in patientsresponserosiglitazonestressorsugar
项目摘要
Project Abstract
Asthma is a common disease characterized by airway hyperresponsiveness (AHR) and a heterogenous
inflammatory profile. In patients with asthma, comorbid obesity is associated with worse asthma control and
decreased efficacy of therapy. The inflammatory profile in patients with comorbid obesity and asthma is typified
by less eosinophilic inflammation and more oxidative and nitrosative (oxo-nitrosative) stress than lean patients
with asthma. The mechanism of this observation is not known. However, patients with comorbid obesity and
asthma have lower levels of paraoxonase 2 (PON2) in their airway epithelium than lean patients with asthma.
Furthermore, PON2 levels are modulated by peroxisome proliferator-activated receptor gamma (PPAR) in
multiple tissues. This proposal examines the role of changes in PON2 and PPAR in contributing to oxo-
nitrosative stress in patients with comorbid obesity and asthma. Using a murine model of diet induced obesity
and ozone exposure as a model of inhaled oxidative stress, this proposal will address three questions. First,
what is the relationship between Pon2 expression and oxo-nitrosative stress under the condition of obesity? This
question will be answered by using a high fat, high sugar diet to induce obesity and an acute ozone exposure as
an exogenous oxidative insult. Pon2 expression, markers of oxo-nitrosative stress, and airway physiology will
be assessed in lean and obese mice to determine if there is an association between Pon2 levels and airway
oxo-nitrosative stress. These findings will be compared to Pon2-/- mice under the same conditions to isolate the
effect of PON2. To isolate the precise role of the pulmonary epithelium in this process, cultured human airway
epithelial cells will be exposed to ozone and assessed for oxo-nitrosative stress. Second, how does Pon2
expression changes affect the development of airway fibrosis after chronic exposure to an oxidative stressor?
This question will be addressed by feeding mice either a high fat, high sugar or a control diet and then chronically
exposing them to ozone for 6 weeks. At the end of six weeks, airway physiology will be measured and lung tissue
will be assessed for the development of fibrosis. Third, does PPAR activation abrogate the effect of obesity on
PON2 expression, AHR and markers of oxo-nitrosative stress? This question will be addressed by treating mice
with the PPAR agonist, pioglitazone, and repeating the high fat, high sugar diet and acute ozone exposures
from our first question. Airway physiology, PON2 levels and oxo-nitrosative stress will then be assessed.
项目摘要
哮喘是一种常见疾病,其特征是气道高反应性(AHR)和异质性
炎症特征。在哮喘患者中,合并肥胖与哮喘控制较差有关,并且
治疗效果下降。肥胖和哮喘共病患者的炎症特征是典型的
与瘦患者相比,嗜酸性粒细胞炎症较少,氧化和亚硝化(氧化亚硝化)应激较多
患有哮喘。这种观察的机制尚不清楚。然而,患有肥胖症并存的患者
与瘦哮喘患者相比,哮喘患者气道上皮中的对氧磷酶 2 (PON2) 水平较低。
此外,PON2 水平受过氧化物酶体增殖物激活受体 γ (PPAR) 的调节
多个组织。该提案研究了 PON2 和 PPAR 的变化在促进氧代-
肥胖和哮喘共病患者的亚硝化应激。使用饮食诱发肥胖的小鼠模型
和臭氧暴露作为吸入氧化应激的模型,该提案将解决三个问题。第一的,
肥胖条件下Pon2表达与氧化亚硝化应激有何关系?这
通过使用高脂肪、高糖饮食诱发肥胖和急性臭氧暴露可以回答这个问题
外源性氧化损伤。 Pon2 表达、氧化亚硝化应激标志物和气道生理学将
在瘦小鼠和肥胖小鼠中进行评估,以确定 Pon2 水平与气道之间是否存在关联
氧化亚硝化应激。这些发现将与相同条件下的 Pon2-/- 小鼠进行比较,以分离
PON2的影响。为了分离肺上皮在此过程中的精确作用,培养了人呼吸道
上皮细胞将暴露于臭氧并评估氧化亚硝化应激。二、Pon2如何
表达变化会影响长期暴露于氧化应激源后气道纤维化的发展吗?
这个问题可以通过给小鼠喂食高脂肪、高糖或对照饮食,然后长期喂养来解决。
将它们暴露在臭氧中 6 周。六周结束时,将测量气道生理学和肺组织
将评估纤维化的发展。第三,PPARα激活是否会消除肥胖对身体的影响?
PON2 表达、AHR 和氧化亚硝化应激标志物?这个问题将通过治疗小鼠来解决
使用 PPAR 激动剂吡格列酮,并重复高脂肪、高糖饮食和急性臭氧暴露
从我们的第一个问题开始。然后将评估气道生理学、PON2 水平和氧化亚硝化应激。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Experience With Trauma-Induced ARDS: A Retrospective Study of US Wartime Casualties 2003-2015.
创伤引起的 ARDS 经验:2003-2015 年美国战时伤亡情况回顾性研究。
- DOI:10.55460/mtvh-oncm
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Nam,JasonJ;McCravy,MatthewS;Haines,KristaL;Thomas,SarahB;Aden,JamesK;Johnston,LukeR;Mason,PhillipE;Gurney,JenniferM;Sams,ValerieG
- 通讯作者:Sams,ValerieG
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew McCravy其他文献
Matthew McCravy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew McCravy', 18)}}的其他基金
The Role of PON2 in the Development of Non-Allergic Asthma in Obesity
PON2 在肥胖引起的非过敏性哮喘发展中的作用
- 批准号:
10533862 - 财政年份:2022
- 资助金额:
$ 8.53万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 8.53万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 8.53万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 8.53万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 8.53万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 8.53万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 8.53万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 8.53万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 8.53万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 8.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 8.53万 - 项目类别:
Standard Grant














{{item.name}}会员




